Skip to main content

Advertisement

Log in

RETRACTED ARTICLE: Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

This article was retracted on 18 August 2015

Abstract

This meta-analysis was performed to evaluate the relationships between promoter DNA methylation in tumor suppressor gene p16 and gastric carcinogenesis. The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library and CBM databases were searched for relevant articles published before November 1st, 2013 without any language restrictions. Meta-analysis was conducted using the STATA 12.0 software. Crude odds ratios (ORs) with 95 % confidence intervals (95 % CI) were calculated. Forty-seven clinical cohort studies that met all inclusion criteria were included in this meta-analysis. A total of 2,813 gastric cancer (GC) patients were assessed. Our meta-analysis results revealed that the frequencies of p16 promoter methylation in the GC tissues were higher than those of normal and adjacent tissues (Normal: OR = 23.04, 95 % CI = 13.55–39.15, P < 0.001; Adjacent: OR = 4.42, 95 % CI = 1.66–11.76, P = 0.003; respectively). Furthermore, we observed significant associations of p16 promoter methylation with TNM stage, histologic grade, invasive grade, lymph node metastasis of GC (TNM stage: OR = 3.60, 95 % CI: 2.17–5.98, P < 0.001; Histologic grade: OR = 2.63, 95 % CI: 1.55–4.45, P < 0.001; Invasive grade: OR = 3.44, 95 % CI: 1.68–7.06, P = 0.001; Lymph node metastasis: OR = 2.68, 95 % CI: 1.66–4.32, P < 0.001; respectively). However, there were no correlations of p16 promoter methylation with the TNM stage and Helicobacter pylori (HP) infection of GC (Tumor size: OR = 0.76, 95 % CI: 0.14–4.07, P = 0.746; HP infection: OR = 1.31, 95 % CI: 0.75–2.27, P = 0.342; respectively). Our findings provide empirical evidence that p16 promoter methylation may play an important role in gastric carcinogenesis. Thus, p16 promoter methylation may be a promising potential biomarker for the early diagnosis of GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Zhao Q, Wang J, Zou MJ, Hu R, Zhao L, Qiang L, Rong JJ, You QD, Guo QL (2010) Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of nf-kappab and regulation of its metabolism. Toxicol Lett 197:201–210. doi:10.1016/j.toxlet.2010.05.019

    Article  CAS  PubMed  Google Scholar 

  2. Wani M, Afroze D, Makhdoomi M, Hamid I, Wani B, Bhat G, Wani R, Wani K (2012) Promoter methylation status of DNA repair gene (hmlh1) in gastric carcinoma patients of the kashmir valley. APJCP 13:4177–4181. doi:10.7314/APJCP.2012.13.8.4177

    Google Scholar 

  3. Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M, Shinomura Y (2011) Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 83:241–249. doi:10.1159/000320453

    Article  CAS  PubMed  Google Scholar 

  4. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA (2010) Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 59:39–48. doi:10.1136/gut.2009.191080

    Article  CAS  PubMed  Google Scholar 

  5. Takachi R, Inoue M, Shimazu T, Sasazuki S, Ishihara J, Sawada N, Yamaji T, Iwasaki M, Iso H, Tsubono Y, Tsugane S (2010) Consumption of sodium and salted foods in relation to cancer and cardiovascular disease: the Japan Public Health Center-based prospective study. Am J Clin Nutr 91:456–464. doi:10.3945/ajcn.2009.28587

    Article  CAS  PubMed  Google Scholar 

  6. Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A’Rabi A, Forghani MN, Raziee HR, Mashhadinejad A, Jafarzadeh M, Esmaili-Shandiz E, Dadkhah E (2008) P16 promoter hypermethylation: A useful serum marker for early detection of gastric cancer. World J Gastroenterol 14:2055-2060

    Google Scholar 

  7. Ushijima T, Yoshida S (2012) Genetic and epigenetic alterations in gastric carcinogenesis. Nihon rinsho Jap J Clin Med 70:1705-1714

    Google Scholar 

  8. Ojima H, Saito K, Yamauchi H, Yamaki E, Idetu A, Hosouchi Y, Nishida Y, Tukada K, Kato H, Kuwano H (2006) P16 protein abnormality in epstein-barr virus-associated gastric carcinomas. Anticancer Res 26:933-937

    Google Scholar 

  9. Galderisi U, Jori FP, Giordano A (2003) Cell cycle regulation and neural differentiation. Oncogene 22:5208–5219. doi:10.1038/sj.onc.1206558

    Article  CAS  PubMed  Google Scholar 

  10. Pinto RP, Lima FK, Kulkzynski JM, Moreira LF (2009) Expression of p16 and pdgfr-beta in gastric adenocarcinoma. Rev Col Bras Cir 36:199–203

    Google Scholar 

  11. Piepkorn M (2000) Melanoma genetics: An update with focus on the cdkn2a(p16)/arf tumor suppressors. J Am Acad Dermatol 42:705-722; quiz 723-706

    Google Scholar 

  12. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastr Canc 8:86–94. doi:10.1007/s10120-005-0320-0

    Google Scholar 

  13. Mokrowiecka A, Wierzchniewska-Lawska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E (2012) P16 gene mutations in Barrett’s esophagus in gastric metaplasia - intestinal metaplasia - dysplasia - adenocarcinoma sequence. Adv Med Sci 57:71–76. doi:10.2478/v10039-012-0003-0

    Article  CAS  PubMed  Google Scholar 

  14. Kang GH (2012) Cpg island hypermethylation in gastric carcinoma and its premalignant lesions. Korean J Pathol 46:1–9. doi:10.4132/KoreanJPathol.2012.46.1.1

    Article  PubMed Central  PubMed  Google Scholar 

  15. Tamura G (2004) Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol 19:221-228

    Google Scholar 

  16. Jia AP, Lian XL, Hu HB (2011) The relationship between p16 gene methylation and clinical pathology of gastric carcinoma. Acta Med Sinia 24:254–257. doi:10.3969/j.issn.1008-2409.2011.03.003

    CAS  Google Scholar 

  17. Li TC, Jiang DP, Lu LM, Zhao GH (2007) p16 protein expression and promoter methylation of p16 gene in gastric cancer. J Pract Med 23:3812–3814. doi:10.3969/j.issn.1006-5725.2007.24.003

    CAS  Google Scholar 

  18. Liao AJ, Ling QH, Liu GX, Cao RX, Shi W (2001) The methyolation status of exon1 of p16 gene in human gastric cancer. Pract J Cancer 16:284–287

    Google Scholar 

  19. Lv P, Ling ZQ, Yu JL, Han J, Wang S, Wang XB, Yu QM, Fang XH (2013) Methylation status of p16 gene in gastric cancer tissue and its clinical significance. J Chin Oncol 19:332-335

    Google Scholar 

  20. Yang LT, Xu W, Liu SX, Wu YZ, Liu P (2012) Detection of p16 and mgmt promoter methylation in gastric carcinomas and its clinical significance. Shandong Med 52:47–48. doi:10.3969/j.issn.1002-266X.2012.31.018

    Google Scholar 

  21. Chen Y (2008) Methylation of p16 gene in gastric cancer. Shandong Med J 48:86–87. doi:10.3969/j.issn.1002-266X.2008.37.046

    CAS  Google Scholar 

  22. Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W (2006) Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 106:1250–1259. doi:10.1002/cncr.21754

    Article  CAS  PubMed  Google Scholar 

  23. Zhao YF, Tian XX, Du J, Zhang YG, Liu SN, Zheng J (2003) Methylation and expression of gene p16 and rb in gastric carcinomas. J Peking Univ (Health Sci) 35:382–385

    CAS  Google Scholar 

  24. Stang A (2010) Critical evaluation of the newcastle–ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. doi:10.1007/s10654-010-9491-z

    Article  PubMed  Google Scholar 

  25. Zintzaras E, Ioannidis JP (2005) Hegesma: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672–3673. doi:10.1093/bioinformatics/bti536

    Article  CAS  PubMed  Google Scholar 

  26. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–680. doi:10.1001/jama.295.6.676

    Article  CAS  PubMed  Google Scholar 

  27. Chen G, Zheng TR, Zheng QH, Gong FS, Zhao CL, Hu D (2006) Correlation of p16ink4a promoter hypermethylation with p16ink4a protein loss in gastric carcinomas. Chin J Clin Exp Pathol 22:567–570. doi:10.3969/j.issn.1001-7399.2006.05.014

    CAS  Google Scholar 

  28. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S (2004) Increased DNA methyltransferase 1 (dnmt1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple cpg islands in gastric cancers. Am J Pathol 164:689–699. doi:10.1016/s0002-9440(10)63156-2

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Hibi K, Koike M, Nakayama H, Fujitake S, Kasai Y, Ito K, Akiyama S, Nakao A (2003) A cancer-prone case with a background of methylation of p16 tumor suppressor gene. Clin Cancer Res 9:1053-1056

    Google Scholar 

  30. House MG, Guo M, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV (2003) Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J Gastrointest Surg 7:1004–1014 (discussion 1014)

    Article  PubMed  Google Scholar 

  31. Huang DB, Hu SL, Sun YB, Xu WP, Shen G, Chen J (2009) Analysis of aberrant methylation of p16 gene promoter in tissue from gastric cancer patients. Shandong Med J 49:1–3. doi:10.3969/j.issn.1002-266X.2009.01.001

    Article  CAS  Google Scholar 

  32. Ichikawa D, Koike H, Ikoma H, Ikoma D, Tani N, Otsuji E, Kitamura K, Yamagishi H (2004) Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. Anticancer Res 24:2477–2481

    CAS  PubMed  Google Scholar 

  33. Jang TJ, Kim DI, Shin YM, Chang HK, Yang CH (2001) P16(ink4a) promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation. Int J Cancer 93:629-634. doi:10.1002/ijc.1394

    Google Scholar 

  34. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG (2001) Cpg island methylation in premalignant stages of gastric carcinoma. Cancer Research 61:2847-2851

    Google Scholar 

  35. Kanyama Y, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A (2003) Detection of p16 promoter hypermethylation in serum of gastric cancer patients. Cancer Sci 94:418-420. doi:10.1111/j.1349-7006.2003.tb01457.x

    Google Scholar 

  36. Kim H, Kim YH, Kim SE, Kim NG, Noh SH (2003) Concerted promoter hypermethylation of hmlh1, p16ink4a, and e-cadherin in gastric carcinomas with microsatellite instability. J Pathol 200:23–31. doi:10.1002/path.1325

    Article  CAS  PubMed  Google Scholar 

  37. Koike H, Ichikawa D, Ikoma H, Tani N, Ikoma D, Otsuji E, Okamoto K, Ueda Y, Kitamura K, Yamagishi H (2005) Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepatogastroenterology 52:1293–1296

    CAS  PubMed  Google Scholar 

  38. Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ, To KF (2002) Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8:1761-1766

    Google Scholar 

  39. Leung WK, To KF, Chu ES, Chan MW, Bai AH, Ng EK, Chan FK, Sung JJ (2005) Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 92:2190–2194. doi:10.1038/sj.bjc.6602636

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, Go MY, Chung SC, Sung JJ (2001) Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91:2294–2301. doi:10.1002/1097-0142(20010615)91:12<2294:AID-CNCR1261>3.0.CO;2-G

    Google Scholar 

  41. Li Q, Zhao LZ, Wang YF, Guo CL, Cao HR, Bai XF (2007) Clinical significance of promoter methylation of p16 gene in gastric cancer. Acta Acad Med Neimongol 29:33–36. doi:10.3969/j.issn.1004-2113.2007.01.010

    Google Scholar 

  42. Li SJ, Yuan H, Liu XY (2005) The clinical study of the methylation in gene p16 in early diagnosis in stomach cancer. Chin J Misdiagnostics 20:607-609

    Google Scholar 

  43. Liu WT, Jiao HL, Yang YL, Wang D, Zhang WM (2007) Correlation of p16 hypermethylation with tumorigenesis and the development of gastric cancer. World Chin J Digestol 15:2839–2843. doi:10.3969/j.issn.1009-3079.2007.26.016

    CAS  Google Scholar 

  44. Liu YH, Zhang LH, Ren H, Zhang GG, Qin F, Kong GZ, Deng GR, Ji JF (2005) Promoter hypermethylation of the p16 gene in pre- and post-gastrectomy plasma of patients with gastric adenocarcinoma. J Peking Univ (Health Sci) 37(3):257–260

    CAS  Google Scholar 

  45. Luo D, Zhang B, Lv L, Xiang S, Liu Y, Ji J, Deng D (2006) Methylation of cpg islands of p16 associated with progression of primary gastric carcinomas. Lab Invest 86:591–598. doi:10.1038/labinvest.3700415

    CAS  PubMed  Google Scholar 

  46. Min KO, Seo EJ, Kwon HJ, Lee EJ, Kim WI, Kang CS, Kim KM (2006) Methylation of p16(ink4a) and p57(kip2) are involved in the development and progression of gastric malt lymphomas. Mod Pathol 19:141–148. doi:10.1038/modpathol.3800505

    Article  CAS  PubMed  Google Scholar 

  47. Mino A, Onoda N, Yashiro M, Aya M, Fujiwara I, Kubo N, Sawada T, Ohira M, Kato Y, Hirakawa K (2006) Frequent p16 cpg island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway. Oncol Rep 15:615–620

    CAS  PubMed  Google Scholar 

  48. Oue N, Motoshita J, Yokozaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K, Yasui W (2002) Distinct promoter hypermethylation of p16ink4a, cdh1, and rar-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 198:55–59. doi:10.1002/path.1170

    Article  CAS  PubMed  Google Scholar 

  49. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W (2003) DNA methylation of multiple genes in gastric carcinoma: Association with histological type and cpg island methylator phenotype. Cancer Sci 94:901–905. doi:10.1111/j.1349-7006.2003.tb01373.x

    Google Scholar 

  50. She YL, Zhang X, Li NL, Zhang X, Wang YL, Wang XM, Hu SM, Luo YL (2010) Correlation of p16 gene methylation with protein expression in gastric cancer and its clinical significance. Tumor 30:1038–1041. doi:10.3781/j.issn.1000-7431.2010.12.009

    CAS  Google Scholar 

  51. Shi W, Liao AJ, Liu GX (2001) Correlations of HP infection and p16 prompter methylation with gastric cancer. Chin J Dig Endosc 16:400-402

    Google Scholar 

  52. Sun Y, Deng D, You WC, Bai H, Zhang L, Zhou J, Shen L, Ma JL, Xie YQ, Li JY (2004) Methylation of p16 cpg islands associated with malignant transformation of gastric dysplasia in a population-based study. Clin Cancer Res 10:5087–5093. doi:10.1158/1078-0432.ccr-03-0622

    Article  CAS  PubMed  Google Scholar 

  53. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K (1999) Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83:309–313. doi:10.1002/(SICI)1097-0215(19991029)83:3<309::AID-IJC4>3.0.CO;2-Z

    Google Scholar 

  54. Tang SH, Yang DH, Luo HS, Yu JP, Shu JC (2004) Relationship between alterations of p16ink4a and p14arf genes of cdkn2a locus and gastric carcinogenesis. Chin J Epidemiol 25:517–521

    Google Scholar 

  55. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC, Sung JJ (2002) Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 102:623–628. doi:10.1002/ijc.10783

    Article  CAS  PubMed  Google Scholar 

  56. Tsujimoto H, Hagiwara A, Sugihara H, Hattori T, Yamagishi H (2002) Promoter methylations of p16ink4a and p14arf genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type. Pathol Res Pract 198:785–794. doi:10.1078/0344-0338-00337

    Article  CAS  PubMed  Google Scholar 

  57. Vo QN, Geradts J, Boudreau DA, Bravo JC, Schneider BG (2002) Cdkn2a promoter methylation in gastric adenocarcinomas: clinical variables. Hum Pathol 33:1200–1204. doi:10.1053/hupa.2002.130108

    Article  CAS  PubMed  Google Scholar 

  58. Wang Y, Zhou L, Chen XQ, Zhang W, Wang L (2010) Detection of p16 and mgmt promoter methylation in gastric carcinomas by nested methylation-specific polymerase chain reaction. World Chi J Digestol 18:384–387. doi:10.3969/j.issn.1009-3079.2010.04.013

    CAS  Google Scholar 

  59. Wei GH, Yang CY, Yang J, Gao ZA (2011) Effects of hp infection and methylation of p16 gene on the pathogenesis of gastric carcinoma. Cancer Res Prev Treat 38:51–54. doi:10.3971/j.issn.1000-8578.2011.01.015

    CAS  Google Scholar 

  60. Yan XE, Zhou LY, Lin SR (2006) The value of p16 and death-associated protein kinase methylation and autofluroscene spectrum analysis of gastric juice in diagnosing gastric carcinoma. Chin J Dig 26:726-730

    Google Scholar 

  61. Yang YX, Kong XD, Zhang SZ (2002) P16 and p15 gene expression and the methylation status abnoramalities of p16 and p15 gene promotor in gastric cancer. Basic Med Sci Clin 22:318–323. doi:10.3969/j.issn.1001-6325.2002.04.007

    Google Scholar 

  62. Yu SL, Fei SJ, Zhang LF (2005) Detection of p16 gene methylation by methylation-specific pcr and its clinical significance in gastric cancer. Acta Acad Med 25:289–290

    CAS  Google Scholar 

  63. Zhang B, Cao J, Liu WJ, Chen M, Zou XP (2009) Study on methylation and expressions of p16ink4a, runx3 and o-6-methylguanine-DNA methyltransferase genes in gastdc carcinogenesis. Chin J Dig 29:177–182. doi:10.3760/cma:j.issn:0254-1432.2009.03.011

    CAS  Google Scholar 

  64. Zhang F, Wang L, Wu PP, Yan ZW, Zheng L, Yu YY, Jiang XC (2004) In situ analysis of p16/ink4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma. Chin J Dig Dis 5:149–155. doi:10.1111/j.1443-9573.2004.00172.x

    Article  CAS  PubMed  Google Scholar 

  65. Zhao CH, Zhang N, Bu XM, Li Y, Zhang HP (2006) Detection of multiple gene methylation in gastric cancer. World Chin J Digestol 14:1004–1007. doi:10.3969/j.issn.1009-3079.2006.10.015

    CAS  Google Scholar 

  66. Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130:1715–1725. doi:10.1002/ijc.27316

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  67. Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A’rabi A, Forghani MN, Raziee HR, Mashhadinejad A, Jafarzadeh M, Esmaili-Shandiz E (2008) P16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol 14:2055

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Huang Q, Ai L, Zhang ZY, Fan C-Y, Weiss LM (2004) Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of b-cell primary gastric lymphomas from china. Mod Pathol 17:416–422

    Article  CAS  PubMed  Google Scholar 

  69. Jeong YJ, Jeong HY, Lee SM, Bong JG, Park SH, Oh HK (2013) Promoter methylation status of the fhit gene and fhit expression: association with her2/neu status in breast cancer patients. Oncol Rep 30:2270–2278. doi:10.3892/or.2013.2668

    CAS  PubMed  Google Scholar 

  70. Dai W, Zeller C, Masrour N, Siddiqui N, Paul J, Brown R (2013) Promoter cpg island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer. Clin Cancer Res 19:5788–5797. doi:10.1158/1078-0432.CCR-13-1217

    Article  CAS  PubMed  Google Scholar 

  71. Wu PY, Zhang Z, Wang JM, Guo WW, Xiao N, He Q, Wang YP, Fan YM (2012) Germline promoter hypermethylation of tumor suppressor genes in gastric cancer. World J Gastroenterol 18:70–78. doi:10.3748/wjg.v18.i1.70

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. do Nascimento Borges B, Burbano RM, Harada ML (2013) Analysis of the methylation patterns of the p16 ink4a, p15 ink4b, and apc genes in gastric adenocarcinoma patients from a brazilian population. Tumour Biol 34:2127–2133. doi:10.1007/s13277-013-0742-y

    Article  PubMed  Google Scholar 

  73. Jha AK, Nikbakht M, Jain V, Capalash N, Kaur J (2012) P16(ink4a) and p15(ink4b) gene promoter methylation in cervical cancer patients. Oncol Lett 3:1331–1335. doi:10.3892/ol.2012.655

    PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Research Foundation of Science and Technology Agency of Liaoning Province (No. 2011408004). We would like to acknowledge the reviewers for their helpful comments on this paper.

Conflict of interests

The authors have declared that no competing interests exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to He-Ling Wang.

Additional information

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

About this article

Cite this article

Wang, HL., Zhou, PY., Liu, P. et al. RETRACTED ARTICLE: Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis. Mol Biol Rep 41, 4481–4492 (2014). https://doi.org/10.1007/s11033-014-3319-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3319-y

Keywords

Navigation